Yi-Rou Wang1, Nai-Xin Xu2, Jian Wang1,3, Xiu-Min Wang4,5. 1. Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China. 2. Huaxi Medical College School of Sichuan University, Sichuan, China. 3. Department of Genetics, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China. 4. Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China. wangxiumin1019@126.com. 5. Department of Genetics, Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine, Shanghai, China. wangxiumin1019@126.com.
Abstract
BACKGROUND: Kabuki syndrome (KS), is a infrequent inherited malformation syndrome caused by mutations in a H3 lysine 4 methylase (KMT2D) or an X-linked histone H3 lysine 27 demethylase (UTX/KDM6A). The characteristics in patients with KS have not yet been well recognized. DATA SOURCES: We used databases including PubMed and Google Scholar to search for publications about the clinical features and the etiology of Kabuki syndrome. The most relevant articles to the scope of this review were chosen for analysis. RESULTS: Clinical diagnosis of KS is challenging in initial period, because many clinical characteristics become apparent only in subsequent years. Recently, the genetic and functional interaction between KS-associated genes and their products have been elucidated. New clinical findings were reported including nervous system and intellectual performance, endocrine-related disorders and immune deficiency and autoimmune disease. Cancer risks of Kabuki syndrome was reviewed. Meanwhile, we discussed the Kabuki-like syndrome. Digital clinical genetic service, such as dysmorphology database can improve availability and provide high-quality diagnostic services. Given the significant clinical relevance of KS-associated genes and epigenetic modifications crosstalk, efforts in the research for new mechanisms are thus of maximum interest. CONCLUSIONS: Kabuki syndrome has a strong clinical and biological heterogeneity. The main pathogenesis of Kabuki syndrome is the imbalance between switch-on and -off of the chromatin. The direction of drug research may be to regulate the normal opening of chromatin. Small molecule inhibitors of histone deacetylases maybe helpful in treatment of mental retardation and reduce cancer risk in KS.
BACKGROUND:Kabuki syndrome (KS), is a infrequent inherited malformation syndrome caused by mutations in a H3 lysine 4 methylase (KMT2D) or an X-linked histone H3 lysine 27 demethylase (UTX/KDM6A). The characteristics in patients with KS have not yet been well recognized. DATA SOURCES: We used databases including PubMed and Google Scholar to search for publications about the clinical features and the etiology of Kabuki syndrome. The most relevant articles to the scope of this review were chosen for analysis. RESULTS: Clinical diagnosis of KS is challenging in initial period, because many clinical characteristics become apparent only in subsequent years. Recently, the genetic and functional interaction between KS-associated genes and their products have been elucidated. New clinical findings were reported including nervous system and intellectual performance, endocrine-related disorders and immune deficiency and autoimmune disease. Cancer risks of Kabuki syndrome was reviewed. Meanwhile, we discussed the Kabuki-like syndrome. Digital clinical genetic service, such as dysmorphology database can improve availability and provide high-quality diagnostic services. Given the significant clinical relevance of KS-associated genes and epigenetic modifications crosstalk, efforts in the research for new mechanisms are thus of maximum interest. CONCLUSIONS:Kabuki syndrome has a strong clinical and biological heterogeneity. The main pathogenesis of Kabuki syndrome is the imbalance between switch-on and -off of the chromatin. The direction of drug research may be to regulate the normal opening of chromatin. Small molecule inhibitors of histone deacetylases maybe helpful in treatment of mental retardation and reduce cancer risk in KS.
Entities:
Keywords:
Cancer risk; KDM6A; KMT2D; Kabuki syndrome; Kabuki-like syndrome
Authors: S Baer; A Afenjar; T Smol; A Piton; B Gérard; Y Alembik; T Bienvenu; G Boursier; O Boute; C Colson; M-P Cordier; V Cormier-Daire; B Delobel; M Doco-Fenzy; B Duban-Bedu; M Fradin; D Geneviève; A Goldenberg; M Grelet; D Haye; D Heron; B Isidor; B Keren; D Lacombe; A-S Lèbre; G Lesca; A Masurel; M Mathieu-Dramard; C Nava; L Pasquier; A Petit; N Philip; J Piard; S Rondeau; P Saugier-Veber; S Sukno; J Thevenon; J Van-Gils; C Vincent-Delorme; M Willems; E Schaefer; G Morin Journal: Clin Genet Date: 2018-05-17 Impact factor: 4.438
Authors: Dina A Schott; Marinus J Blok; Willem J M Gerver; Koenraad Devriendt; Luc J I Zimmermann; Constance T R M Stumpel Journal: Am J Med Genet A Date: 2016-08-17 Impact factor: 2.802
Authors: Karin Writzl; Catherine M Cale; Christine M Pierce; Louise C Wilson; Raoul C M Hennekam Journal: Eur J Med Genet Date: 2007-05-27 Impact factor: 2.708
Authors: Sarah K Baxter; Tom Walsh; Silvia Casadei; Mary M Eckert; Eric J Allenspach; David Hagin; Gesmar Segundo; Ming K Lee; Suleyman Gulsuner; Brian H Shirts; Kathleen E Sullivan; Michael D Keller; Troy R Torgerson; Mary-Claire King Journal: J Allergy Clin Immunol Date: 2021-04-20 Impact factor: 10.793
Authors: Wei Yin; Dimitrios Arkilo; Polyna Khudyakov; Jim Hazel; Saurabh Gupta; Maria S Quinton; Jie Lin; Deborah S Hartman; Martin M Bednar; Laura Rosen; Jens R Wendland Journal: Br J Clin Pharmacol Date: 2021-06-10 Impact factor: 3.716
Authors: Jens Wittner; Sebastian R Schulz; Tobit D Steinmetz; Johannes Berges; Manuela Hauke; William M Channell; Adam F Cunningham; Anja E Hauser; Andreas Hutloff; Dirk Mielenz; Hans-Martin Jäck; Wolfgang Schuh Journal: Mucosal Immunol Date: 2022-03-28 Impact factor: 8.701
Authors: Francesca Di Candia; Paolo Fontana; Pamela Paglia; Mariateresa Falco; Carmen Rosano; Carmelo Piscopo; Gerarda Cappuccio; Maria Anna Siano; Daniele De Brasi; Claudia Mandato; Ilaria De Maggio; Gabriella Maria Squeo; Matteo Della Monica; Gioacchino Scarano; Fortunato Lonardo; Pietro Strisciuglio; Giuseppe Merla; Daniela Melis Journal: Eur J Pediatr Date: 2021-07-07 Impact factor: 3.183